C.R.S. Section 18-18-303
Registration

(1)

The board or BHA shall register an applicant to manufacture or distribute substances included in schedules I through V unless the board or BHA determines that the issuance of that registration would be inconsistent with the public interest. In determining the public interest, the board or BHA shall consider the following factors:

(a)

Maintenance of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels;

(b)

Compliance with applicable state and local law;

(c)

Promotion of technical advances in the art of manufacturing controlled substances and the development of new substances;

(d)

Any convictions of the applicant under any laws of another country or federal or state laws relating to any controlled substance;

(e)

Past experience of the applicant in the manufacture or distribution of controlled substances, and the existence in the applicant’s establishment of effective controls against diversion of controlled substances into other than legitimate medical, scientific, research, or industrial channels;

(f)

Furnishing by the applicant of false or fraudulent material in any application filed under this article;

(g)

Suspension or revocation of the applicant’s federal registration or the applicant’s registration of another state to manufacture, distribute, or dispense controlled substances as authorized by federal law; and

(h)

Any other factors relevant to and consistent with the public health and safety.

(2)

Registration under subsection (1) of this section entitles a registrant to manufacture or distribute a substance included in schedule I or II only if it is specified in the registration.

(3)

A practitioner must be registered with the board or BHA before dispensing a controlled substance or conducting research with respect to a controlled substance included in schedules II through V. The BHA need not require separate registration under this article 18 for practitioners engaging in research with nonnarcotic substances included in schedules II through V where the registrant is already registered under this article 18 in another capacity. Practitioners registered under federal law to conduct research with substances included in schedule I may conduct research with substances included in schedule I within this state upon furnishing the BHA evidence of that federal registration.

(4)

A manufacturer or distributor registered under the federal “Controlled Substances Act”, 21 U.S.C. sec. 801 et seq., may submit a copy of the federal application as an application for registration as a manufacturer or distributor under this section. The board may require a manufacturer or distributor to submit information in addition to the application for registration under the federal act.

(5)

Persons licensed or registered under article 280 of title 12 or article 220, 240, 275, 290, or 315 of title 12 need not be licensed separately to distribute or dispense controlled substances to the extent provided under law if they are registered or are exempt from registration by the federal drug enforcement administration, provided that such persons indicate on any initial application or renewal application the schedules of controlled substances that the persons are authorized to use under Public Law 91-513, known as the federal “Comprehensive Drug Abuse Prevention and Control Act of 1970”.

Source: Section 18-18-303 — Registration, https://leg.­colorado.­gov/sites/default/files/images/olls/crs2023-title-18.­pdf (accessed Dec. 24, 2024).

18‑18‑101
Short title 18‑18‑102
Definitions 18‑18‑103
Special definition - board 18‑18‑201
Authority to control 18‑18‑202
Nomenclature 18‑18‑203
Schedule I 18‑18‑204
Schedule II 18‑18‑205
Schedule III 18‑18‑206
Schedule IV - repeal 18‑18‑207
Schedule V 18‑18‑301
Rules 18‑18‑302
Registration requirements - definitions 18‑18‑303
Registration 18‑18‑304
Suspension or revocation of registration 18‑18‑305
Order to show cause 18‑18‑306
Records of registrants 18‑18‑307
Order forms 18‑18‑308
Prescriptions 18‑18‑309
Diversion prevention and control 18‑18‑401
Legislative declaration 18‑18‑402
Definitions - terms used 18‑18‑403
Additional definition 18‑18‑403.5
Unlawful possession of a controlled substance - notice to revisor of statutes - repeal 18‑18‑404
Unlawful use of a controlled substance 18‑18‑405
Unlawful distribution, manufacturing, dispensing, or sale 18‑18‑406
Offenses relating to marijuana and marijuana concentrate - definitions 18‑18‑406.1
Unlawful use or possession of synthetic cannabinoids or salvia divinorum 18‑18‑406.2
Unlawful distribution, manufacturing, dispensing, sale, or cultivation of synthetic cannabinoids or salvia divinorum 18‑18‑406.3
Medical use of marijuana by persons diagnosed with debilitating medical conditions - unlawful acts - penalty - medical marijuana program cash fund 18‑18‑406.4
Unlawful advertising of marijuana - exception 18‑18‑406.5
Unlawful use of marijuana in a detention facility 18‑18‑406.6
Extraction of marijuana concentrate - definitions 18‑18‑406.9
Unlawful distribution or purchase of dextromethorphan - penalty - preemption - definitions 18‑18‑407
Special offender - definitions 18‑18‑409
Reduction or suspension of sentence for providing substantial assistance 18‑18‑410
Declaration of class 1 public nuisance 18‑18‑411
Keeping, maintaining, controlling, renting, or making available property for unlawful distribution or manufacture of controlled substances 18‑18‑412
Abusing toxic vapors - prohibited 18‑18‑412.5
Unlawful possession of materials to make methamphetamine and amphetamine - penalty 18‑18‑412.7
Sale or distribution of materials to manufacture controlled substances 18‑18‑412.8
Retail sale of methamphetamine precursor drugs - unlawful acts - penalty 18‑18‑413
Authorized possession of controlled substances 18‑18‑414
Unlawful acts - licenses - penalties 18‑18‑415
Fraud and deceit 18‑18‑416
Controlled substances - inducing consumption by fraudulent means 18‑18‑417
Notice of conviction 18‑18‑418
Exemptions 18‑18‑419
Imitation and counterfeit controlled substances act 18‑18‑420
Imitation controlled substances - definitions 18‑18‑421
Imitation controlled substances - determination - considerations 18‑18‑422
Imitation controlled substances - violations - penalties 18‑18‑423
Counterfeit substances prohibited - penalty 18‑18‑424
Imitation controlled substances - exceptions 18‑18‑425
Drug paraphernalia - legislative declaration 18‑18‑426
Drug paraphernalia - definitions 18‑18‑427
Drug paraphernalia - determination - considerations 18‑18‑428
Possession of drug paraphernalia - penalty 18‑18‑429
Manufacture, sale, or delivery of drug paraphernalia - penalty 18‑18‑430
Advertisement of drug paraphernalia - penalty 18‑18‑430.5
Drug paraphernalia - exemption 18‑18‑431
Defenses 18‑18‑432
Drug offender public service and rehabilitation program - definitions 18‑18‑433
Constitutional provisions 18‑18‑434
Offenses relating to natural medicine and natural medicine product - definitions 18‑18‑501
Administrative inspections and warrants 18‑18‑502
Injunctions 18‑18‑503
Cooperative arrangements and confidentiality 18‑18‑504
Pleadings - presumptions - liabilities 18‑18‑505
Judicial review 18‑18‑506
Education and research 18‑18‑601
Pending proceedings - applicability 18‑18‑602
Continuation of rules - application to existing relationships 18‑18‑603
Statutes of limitations 18‑18‑604
Uniformity of interpretation 18‑18‑605
Severability 18‑18‑606
Drug case data collection 18‑18‑607
Safe stations - disposal of controlled substances - medical evaluation - definition
Green check means up to date. Up to date

Current through Fall 2024

§ 18-18-303’s source at colorado​.gov